Clinical Study

Study of Feasibility and Safety of Higher-Dose Dexmedetomidine in Special Outpatient Examination of Pediatric Ophthalmology

Table 3

Vital signs in different stages between 2 μg/kg and 3 μg/kg groups.

Group2 μg/kg group ()3 μg/kg group () value

Heart rate
Presedation123.0 ± 8.8121.8 ± 9.60.545
Onset110.7 ± 10.093.2 ± 7.7<0.001
Examination108.4 ± 6.696.2 ± 6.7<0.001
Recovery121.0 ± 11.0102.1 ± 8.2<0.001

SpO2
Presedation98.8 ± 0.798.8 ± 0.70.851
Onset97.6 ± 0.897.3 ± 0.70.072
Examination97.38 ± 1.0396.92 ± 1.030.014
Recovery98.38 ± 1.0597.98 ± 1.410.230

Mean arterial pressure
Onset83.22 ± 1.9180.84 ± 3.15<0.001
Examination83.22 ± 1.9181.70 ± 2.520.001
Recovery83.22 ± 1.9182.84 ± 1.890.308